Match Document Document Title
6852331 Fabrication of a cartilage implant  
A method of fabricating a cartilage implant including embedding and growing chondrocytes or mesenchymal stem cells in a three-dimensional substrate. The substrate contains randomly rewound...
6852330 Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration  
A biocompatible tissue repair stimulating implant or “scaffold” device, and methods for making and using such a device, are provided. The implant includes one or more layers of a bioabsorbable...
6846853 Calcium phosphate bone graft material, process for making same and osteoimplant fabricated from same  
A calcium phosphate bone graft material comprising an amorphous calcium phosphate glassy phase of from about 30 to about 100 volume % is obtained by plasma spraying calcium phosphate-containing...
6841169 Stabilizer for pharmacons  
The present invention relates to an auxiliary substance for an active substance, such as a pharmacon. The auxiliary substance has a stabilizing action. The auxiliary substance further has a...
6838089 Antigen delivery system and method of production  
The present invention concerns polymer particle vaccine delivery systems in which a water insoluble protein antigen, e.g. a lipidated HpaA protein, is incorporated with particles comprising a...
6822000 Bioerodible poly (orthoesters) from dioxolane-based diketene acetals  
Bioerodible poly(orthoesters) useful as orthopedic implants or vehicles for the sustained delivery of pharmaceutical, cosmetic and agricultural agents contain hydrogen bonding groups and α-hydroxy...
6811767 Liquid droplet aerosols of nanoparticulate drugs  
There invention discloses aqueous dispersions of nanoparticulate aerosol formulations, dry powder nanoparticulate aerosol formulation, propellant-based aerosol formulations, methods of using the...
6805876 Phosphate based biodegradable polymers  
Featured are biodegradable polymers comprising repeat units derived from cyclic phosphate monomers and optionally further comprising repeat units derived from lactide or caprolactone monomers. Also...
6793675 Polysaccharide sponges for cell culture and transplantation  
A polysaccharide sponge characterized by having: (i) an average pore size in the range between about 10 μm to about 300 μm; (ii) an average distance between the pores being the wall thickness of...
6793938 Biodegradable compositions for the controlled release of encapsulated substances  
Pharmaceutical compositions that enable the release of a physiologically active substance over a prolonged period of time following administration to a patient are described. The pharmaceutical...
6773713 Injection molding of living tissues  
The invention features methods of making living tissue constructs having a predetermined shape by providing a negative mold having a defined shape; suspending isolated tissue precursor cells in a...
6773714 Polymeric delivery formulations of leuprolide with improved efficacy  
The present invention is directed to a flowable composition that is suitable for use as a controlled release implant. The flowable composition includes a biodegradable thermoplastic polyester that...
6773699 Light energized tissue adhesive conformal patch  
Consistent with the present invention, tissue adhesive compositions and an associated laser exposure system are provided for bonding or sealing biological tissues. The compositions are comprised of...
6770695 Time release calcium sulfate matrix for bone augmentation  
An implant composition having controlled resorption rate in vivo for stimulating bone growth, a method of making the implant composition, and a kit of implant materials are disclosed. The implant...
6767551 Coating for use with medical devices and method of making same  
The inventive coating may be employed to deliver a pharmaceutical agent to a selected body area that is involved within the insertion or application of a medical device. Such medical devices may...
6767550 Hydroxyapatite based drug delivery implant for cancer treatment  
A hydroxyapatite based bioresorbable material is incorporated with anti-cancer agents to form an implant used for treatment against cancer. Sustained release of the anti-cancer agents may be...
6764698 Controlled drug release system of retinoic acid  
The present invention relates to a controlled drug release system in which a certain ratio or retinoic acid is incorporated into a microsphere comprising biodegradable polymer and amphoteric block...
6761887 Alginate layer system for chondrogenic differentiation of human mesenchymal stem cells  
Disclosed are a composition of chemically defined components which support in vitro and in vivo chondrogenesis of mesenchymal stem cells, a method for in vitro and in vivo chondrogenic induction of...
6761908 Collagen preparation for the controlled release of active substances  
A collagen preparation for the controlled release of active substances is characterized in that it has mixtures of acid-insoluble collagens with different molecular weight distributions.
6759054 Ethylene vinyl alcohol composition and coating  
An ethylene vinyl alcohol coating for an implantable device or prosthesis, such as a stent, is provided. Compositions are also provided for coating the implantable device. The compositions can...
6759431 Compositions and methods for treating or preventing diseases of body passageways  
The present invention provides methods for treating or preventing diseases associated with body passageways, comprising the step of delivering to an external portion of the body passageway a...
6756048 Long time drug-sustained release preparation  
The present invention relates to a sustained release preparation of a lipophilic drug, comprising a drug dispersion wherein the lipophilic drug and a water-soluble substance are dispersed, in a...
6752938 Method of preparing microsphere composite of collagen and bioceramic powder  
This invention provides a method of preparing microsphere composite of collagen and bioceramic powder. This method first mixes a collagen solution with bioceramic powder and alginate, and squeezes...
6743783 Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine  
The present invention relates to a purified, easily produced poly-β-1→4-N-acetylglucosamine (p-GlcNAc) polysaccharide species. The p-GlcNAc of the invention is a polymer of high molecular weight...
6737073 Implant for repairing cartilage having outer surface layers of copolymer and ceramic material  
A biodegradable, biocompatible porous matrix as a scaffold for tissue engineering cartilage is formed of a copolymer of a polyalkylene glycol and an aromatic polyester such as a polyethylene...
6737074 Methods of separating cells, transplanting cells and engineering tissue using fibrin microbeads  
The present invention provides fibrin microbeads that are biologically active and comprise extensively cross-linked fibrin(ogen), and a method for preparing the fibrin microbeads. The present...
6737072 Matrix for tissue engineering formed of a hyaluronic acid ester and hydrolyzed collagen  
A porous composite matrix is formed from a hyaluronic acid derivative and hydrolyzed collagen, which are preferably in a weight ratio range of 30:70 to 99:1. A preferred hyaluronic acid derivative...
6733767 Liquid polymeric compositions for controlled release of bioactive substances  
Controlled release of hydrophobic bioactive substances in vivo over an extended time period and without “bursts” of drug release is achieved using a liquid polymeric composition including a...
6730298 Tissue formation by injecting a cell-polymeric solution that gels in vivo  
Slowly polymerizing polysaccharide hydrogels have been demonstrated to be useful as a means of delivering large numbers of isolated cells via injection. The gels promote engraftment and provide...
6726918 Methods for treating inflammation-mediated conditions of the eye  
Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal...
6726920 Implantable drug delivery patch  
The present invention features devices and methods for delivery of drug to an internal organ surface by delivery of drug directly to the surface of the organ such that the drug traverses the organ...
6726923 Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts  
This invention is a prosthetic device generally placed on the outside surface of the vessel or graft which then elutes antiproliferative drugs or agents from a drug-eluting matrix material. Methods...
6723333 Moulded bodies made of thermoplastic polyurethane containing an active substance  
The invention provides moulded items made from thermoplastic polyurethanes (TPUs), in particular medical articles such as central venous catheters which contain a homogeneous distribution of...
6719993 Calcium phosphate cements prepared from silicate solutions  
Methods are provide for producing flowable compositions, e.g. pastes, that set into calcium phosphate products. In the subject methods, dry reactants that include a calcium source and a phosphate...
6719797 Nucleus augmentation with in situ formed hydrogels  
Artificial disc augmentation for natural intervertebral discs using a solution of polymers. Once inserted into the disc the polymers crosslink to form hydrogels in vivo. Crosslinking of the...
6713081 Ocular therapeutic agent delivery devices and methods for making and using such devices  
Ocular implant devices for the delivery of a therapeutic agent to an eye in a controlled and sustained manner. Dual mode and single mode drug delivery devices are illustrated and described....
6713079 Methods for increasing vascularization and promoting wound healing  
The present invention provides a method of stimulating vascularization at a site in a mammal, said method comprising contacting said site with a matrix comprising gelatin and a nitric oxide...
6706274 Differential delivery of nitric oxide  
This invention relates to devices and methods for the local, differential delivery of nitric oxide within the body. The devices include devices having at least two differing nitric oxide donor...
6706273 Composition for implantation into the human and animal body  
Compositions for implantation into the human and animal body as bone replacement contain inter alia calcium and phosphorus and consist in particular of mixtures of powders and admixing liquids....
6703037 Biodegradable macromers for the controlled release of biologically active substances  
A method for delivering a biologically active substance including the steps of: (a) combining said biologically active substance with a macromer; (b) forming a mixture of the combination formed in...
6703038 Injectable bone substitute material containing non-ceramic hydroxyapatite cement  
A bone substitute material is prepared which comprises a soft matrix, living cells and a setting matrix comprising non-ceramic hydroxyapatite cement. The bone substitute material can be injected...
6703047 Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use  
Compositions and methods are provided for forming tissue-adherent hydrogels using substantially dry precursors. The dehydrated precursors are premixed prior to in situ therapy and utilize...
6699490 Aqueous prolonged release formulation  
Prolonged parenteral release into the circulatory system of a cow of a bioactive bovine somatotropin at desirably effective levels can be achieved using novel compositions in which the bovine...
6699484 Fibrin sealants or adhesives comprising a hyaluronic acid derivative material  
An especially useful fibrin glue composition comprises a biocompatible, bioabsorbable hyaluronic acid derivative material, upon which are applied or chemically bonded fibrinogen and thrombin, along...
6699505 Method of increasing the efficacy of antibiotics by compexing with cyclodextrins  
The present invention provides methods of increasing the biological activity of a bioactive agent by complexing the bioactive agent with a complexing agent. In one preferred embodiment, the...
6696075 Liquid crystalline polymers  
Methods for inducing a thermoplastic polymer, which can be non-mesogenic, to exhibit liquid crystalline properties have been developed. The method includes the steps of (a) heating the polymer from...
6692759 Methods for preparing and using implantable substance delivery devices  
Method for preparing an implantable device for a sustained delivery of a substance within a body of a human or an animal subject, the method including; dissolving a biocompatible polymer in a...
6689375 Resorbable bone implant material and method for producing the same  
The powdery component of the implant material consists essentially of a mixture of hydroxyl apatite powder and calcium sulfate powder, wherein the hydroxyl apatite powder consists of synthetically...
6685957 Preparation of fibrous polymer implant containing bioactive agents using wet spinning technique  
A fibrous polymer implant loaded with one or more bioactive agents is prepared using a wet spinning technique. Preferably, an aqueous solution of bioactive agent is added to a solution of...
6682754 Ovo delivery of an immunogen containing implant  
The disclosure provides a method for administering an agent to an avian species by in ovo delivery of an implant releasably containing the agent. In one embodiment, the method is particularly...